NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge or the Company) a global biotechnology platform company committed to accelerating access to innovative medicines, today announced the presentation of ...

Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients who are relapsed or refractory to checkpoint ...

Finland was the first country to offer the zoonotic avian influenza A(H5N8) vaccine manufactured by Seqirus to at-risk ...

Researchers at Columbia University have found that a lack of dietary iron early in life can prevent immune cells in the lung ...

Researchers at Columbia University have found that a lack of dietary iron early in life can prevent immune cells in the lung ...

Columbia researchers found that iron-deficient mice with influenza were unable to produce a key immune protein in the lungs that helps fight infections, even when iron levels returned to normal.

While mRNA vaccines trigger potent initial immune responses, emerging data suggest they do not generate durable plasma cells, ...

Researchers at Columbia University have found that a lack of dietary iron early in life can prevent immune cells in the lung from making ...

Colorectal cancer immunotherapy advances as Photobacterium angustum identified to selectively colonize tumors with minimal systemic toxicity.

Butantan-DV is the world's first single-dose dengue vaccine and will initially be administered to people aged 12 to 59. Learn more.

Chronic HBV infection remains a major global health burden, with current antiviral therapies effectively suppressing viral ...